Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA
· Real-Time Price · USD
1.25
0.07 (5.93%)
At close: Sep 16, 2025, 3:59 PM
1.25
0.00%
After-hours: Sep 16, 2025, 04:10 PM EDT
Ernexa Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 488K | 535K | 582K | 598K | 162K | 115K | 68K | 51K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | -477K | -437K | 96K | 1.18M | 1.36M | 1.33M | 792K | 331K | 332K | 421K | 497K | 534.4K | 536.81K | 502.1K | 459K | 335.6K | 212.19K | 94.9K |
Gross Profit | 965K | 972K | 486K | -586K | -1.2M | -1.22M | -724K | -280K | -332K | -421K | -497K | -534.4K | -536.81K | -502.1K | -459K | -335.6K | -212.19K | -94.9K |
Operating Income | -10.19M | -12.62M | -15.67M | -18.74M | -21.99M | -21.61M | -21.14M | -20.11M | -22.91M | -32.24M | -33.22M | -37.59M | -115.61M | -111.75M | -113.55M | -106.65M | -22.33M | -14.34M |
Interest Income | 249K | 249K | 249K | n/a | n/a | 24K | 26K | 26K | 26K | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -43.67M | -46.06M | -44.51M | -44.92M | -23.93M | -22.9M | -21.67M | -19.96M | -21.68M | -20.57M | -24.53M | -28.54M | -107.29M | -113.97M | -122.3M | -116.06M | -32.03M | -23.97M |
Net Income | -43.71M | -46.09M | -44.54M | -44.93M | -23.92M | -22.9M | -21.67M | -20M | -21.73M | -10.14M | -17.18M | -21.15M | -99.89M | -117.06M | -122.31M | -116.06M | -32.03M | -23.97M |
Selling & General & Admin | 7.71M | 10.24M | 12.59M | 15.08M | 15.67M | 14.29M | 14.11M | 12.86M | 12.06M | 14.98M | 15.64M | 17.21M | 18.29M | 17.48M | 14.87M | 11.07M | 7.9M | 4.31M |
Research & Development | 4.6M | 4.46M | 4.6M | 4.66M | 5.11M | 5.7M | 5.92M | 6.67M | 10.18M | 10.28M | 10.39M | 12.61M | 9.11M | 12.82M | 12.56M | 10.03M | 9.49M | 5.08M |
Other Expenses | -1.7M | -1.65M | -1.58M | -1.58M | n/a | -280K | -230K | -235K | -235K | 44K | -1.15M | -495K | -507.63K | -528.81K | 609.62K | -37.38K | -24.75K | -16.81K |
Operating Expenses | 10.61M | 13.05M | 15.62M | 18.16M | 20.79M | 19.99M | 20.08M | 19.58M | 22.29M | 25.32M | 26.03M | 29.83M | 27.4M | 30.3M | 27.43M | 21.1M | 17.38M | 9.39M |
Interest Expense | 5.17M | 5.97M | 6.75M | 3.66M | 2.08M | 1.29M | 607K | 225K | 121K | 134K | 30K | 42.03K | 52.24K | 61.24K | 74.24K | 67.73K | 60.08K | 38.08K |
Selling & Marketing Expenses | n/a | n/a | -541K | -1.02M | -1.02M | -1.02M | -481K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.68M | 13.15M | 16.26M | 19.34M | 22.15M | 21.26M | 20.74M | 19.7M | 22.29M | 25.32M | 26.03M | 29.83M | 27.4M | 30.3M | 27.43M | 21.1M | 17.38M | 9.39M |
Income Tax Expense | 28K | 34K | 30K | 15K | -5K | -4K | -3K | 41K | 54K | -10.43M | -7.36M | -7.39M | -7.39M | 3.02M | 14.49M | 14.48M | 14.48M | 14.54M |
Shares Outstanding (Basic) | 5.18M | 53.36M | 51.39M | 5.41M | 5.41M | 5.41M | 5.41M | 5.41M | 5.3M | 5.13M | 4.4M | 2.94M | 2.94M | 2.68M | 2.6M | 2.53M | 2.12M | 1.39M |
Shares Outstanding (Diluted) | 5.18M | 53.36M | 51.39M | 5.41M | 5.41M | 5.41M | 5.41M | 5.41M | 5.3M | 5.13M | 4.4M | 2.94M | 2.94M | 2.68M | 2.6M | 2.53M | 2.12M | 1.39M |
EPS (Basic) | -6.1 | -6.51 | -7.59 | -8.31 | -4.42 | -4.25 | -4.08 | -3.96 | -5.42 | -2.16 | -5.75 | -7.98 | -39.54 | -46.7 | -54.79 | -53.14 | -20.06 | -16.29 |
EPS (Diluted) | -6.1 | -6.51 | -7.59 | -8.31 | -4.42 | -4.25 | -4.08 | -3.96 | -5.42 | -2.16 | -5.74 | -7.97 | -39.53 | -46.69 | -54.79 | -53.14 | -20.06 | -16.29 |
EBITDA | -31.81M | -33.46M | -36.12M | -39.61M | -20.12M | -20M | -19.93M | -18.61M | -20.82M | -20.02M | -24.01M | -27.97M | -106.72M | -113.45M | -121.82M | -115.69M | -31.74M | -23.77M |
EBIT | -33.04M | -34.63M | -37.76M | -41.66M | -22.24M | -21.6M | -21.06M | -19.33M | -21.15M | -20.44M | -24.5M | -28.5M | -107.17M | -113.84M | -122.98M | -116.74M | -32.79M | -24.74M |
Depreciation & Amortization | 643K | 1.17M | 1.64M | 2.05M | 2.12M | 1.6M | 1.12M | 728K | 332K | 421K | 497K | 534.4K | 536.81K | 502.1K | 459K | 360.69K | 262.55K | 169.9K |